Source:http://linkedlifedata.com/resource/pubmed/id/16417211
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-18
|
pubmed:abstractText |
The signaling of CD40 by its ligand, CD154, between T and B cells is required for humoral immune responses. Thus, blockade of this ligand-receptor interaction can prevent the development of antibody-mediated autoimmune diseases through different mechanisms.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/AI40768,
http://linkedlifedata.com/resource/pubmed/grant/AI61430,
http://linkedlifedata.com/resource/pubmed/grant/AR052109,
http://linkedlifedata.com/resource/pubmed/grant/AR07369,
http://linkedlifedata.com/resource/pubmed/grant/AR32081,
http://linkedlifedata.com/resource/pubmed/grant/AR32599
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-202X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
126
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-3
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading | |
pubmed:year |
2006
|
pubmed:articleTitle |
Inhibition of pemphigus vulgaris by targeting of the CD40-CD154 co-stimulatory pathway: a step toward antigen-specific therapy?
|
pubmed:affiliation |
Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA. zhiliu@med.unc.edu
|
pubmed:publicationType |
Journal Article,
Comment,
Research Support, N.I.H., Extramural
|